Very tempted to buy at these prices. Still only trial services, but even translating a few into annual contracts would be huge for SKF.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025